Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-02

FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved the original application (ANDA 213244) for Neostigmine methylsulfate by Eugia US LLC, authorizing its generic entry and labeling for approved indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)